We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of LJPC yet.

LJPC Hedge Fund Activity: Q3 2022 in Review

0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q3 2022, worth a combined $0 — down 100% from $53.9M a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of LJPC and 0 opened new positions — a net loss of 41 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Tang Capital Management, exiting entirely with an estimated $30.6M sold.

  • 0 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q3 2022, down from 41 in Q2 2022.
  • Funds reported $0 of La Jolla Pharmaceutical Company stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new La Jolla Pharmaceutical Company positions in Q3 2022 and 41 closed out, a net change of -41 holders.
  • The largest La Jolla Pharmaceutical Company seller in Q3 2022 was Tang Capital Management, an estimated $30.6M sold.

Based on aggregated 13F filings for Q3 2022.